Substance use disorders are among the world's leading causes of preventable illness and premature death. Alcohol, tobacco, nicotine, and other drugs contribute to millions of deaths each year while increasing the risk of heart disease, cancer, mental illness, and countless other chronic health conditions(1,2). Their impact extends well beyond individual health, affecting families, workplaces, healthcare systems, and entire economies. Alcohol alone is estimated to cost countries roughly 2.6% of their gross domestic product through healthcare expenses, lost productivity, accidents, and other societal costs(3).
Although addiction is often viewed as a problem of willpower, decades of research tell a different story. Addiction changes the brain systems involved in reward, stress, learning, and self-control. Recovery, therefore, is rarely about simply making better choices. It requires rebuilding the brain's ability to regulate emotions, tolerate stress, and resist powerful cravings.
Fortunately, effective treatments already exist.
Cognitive behavioral therapy (CBT) helps people recognize unhealthy thinking patterns and develop healthier coping strategies. Contingency management reinforces positive behaviors by providing tangible rewards for remaining substance-free. Both approaches have strong scientific support and remain important parts of modern addiction treatment(4,5).
The challenge is accessibility. These therapies often require trained clinicians, repeated appointments, and substantial financial resources. Many people never receive treatment because of cost, limited availability, transportation barriers, or shortages of qualified providers.
Could a simple, inexpensive practice that nearly everyone can learn provide additional support during recovery?
One promising candidate is controlled breathing.
Breathing is one of the few body functions that operates automatically yet can also be consciously controlled. This unique connection allows breathing to influence systems that regulate stress, emotions, and attention.
A useful analogy is to think of these systems as the accelerator and brake in a car. Healthy functioning depends on both. Problems arise when the accelerator remains pressed for too long.
Many people living with substance use disorders spend much of their time in this heightened state of physiological stress. Anxiety, withdrawal symptoms, emotional distress, and drug-related cues repeatedly activate the body's stress response, making cravings more intense and self-control more difficult(6).
Controlled breathing appears to help restore balance by increasing parasympathetic activity while reducing excessive sympathetic activation. Rather than eliminating stress, it may improve the body's ability to recover from it.
Researchers often measure this balance using heart rate variability (HRV). Despite what many people assume, a healthy heart does not beat with perfect regularity. Instead, there are tiny, constantly changing differences in the time between heartbeats. These natural fluctuations reflect how flexibly the nervous system responds to changing physical and emotional demands.
Higher HRV generally indicates that the brain and body can adapt efficiently to stress. Lower HRV suggests a less flexible stress-response system that may struggle to recover from challenging situations(7).
Studies have consistently shown that people with alcohol use disorder often have lower HRV than healthy individuals(8). At the same time, higher HRV has been associated with a greater likelihood of maintaining abstinence, and changes in HRV during exposure to alcohol-related cues can help predict relapse risk(9).
These findings suggest that HRV may reflect an individual's capacity for emotional regulation during recovery.
Controlled breathing has already been shown to reduce stress, anxiety, pain, and symptoms of depression across a variety of clinical settings(10).
One specialized approach, known as heart rate variability biofeedback (HRV biofeedback), combines slow breathing with real-time feedback from a wearable sensor. As people breathe, they can immediately see how their heart rhythm responds, allowing them to gradually learn breathing patterns that promote greater physiological stability.
This feedback functions much like a coach during athletic training. Instead of guessing whether a technique is working, people receive immediate information that helps them refine their performance.
A recent randomized clinical trial found that HRV biofeedback reduced cravings among people with substance use disorders compared with standard care(11). However, until recently, it remained unclear whether these benefits were unique to biofeedback or whether simpler breathing exercises might produce similar improvements.
To answer this question, researchers conducted a systematic review and meta-analysis.
Unlike a single clinical trial, a meta-analysis combines data from multiple studies to estimate the overall effect of an intervention. By pooling evidence from many independent investigations, researchers can reach conclusions that are generally more reliable than those based on any individual study.
The investigators searched eight major scientific databases for studies published through November 2025. Eligible studies included people using alcohol, nicotine, tobacco, or other drugs and evaluated breathing as the primary intervention. Overall, the review included 20 studies involving 1,249 participants.
The clearest finding was that breathing-based interventions produced a consistent reduction in craving, one of the strongest predictors of relapse. Across nearly 700 participants, breathing interventions produced a statistically significant, though modest, reduction in craving compared with control groups. Importantly, the studies showed relatively consistent results despite differences in participant populations, treatment settings, and breathing techniques.
A small effect size should not be mistaken for an unimportant one.
In medicine, even modest improvements can have public health benefits when an intervention is inexpensive, safe, easy to learn, and widely available. Vaccination campaigns, blood pressure control, and smoking cessation programs all demonstrate that relatively small improvements, applied across large populations, can translate into substantial health gains.
Breathing exercises may offer similar advantages. They require little equipment, carry minimal risk, and can often be practiced independently after brief instruction.
Interestingly, the review found benefits for both traditional breathing exercises and HRV biofeedback.
The available evidence suggests they may serve somewhat different purposes. Standard breathing exercises appeared particularly effective at reducing cravings immediately after a practice session, making them potentially useful during moments of acute stress or temptation.
HRV biofeedback, in contrast, showed stronger evidence for producing improvements over repeated training sessions, suggesting that regular practice may strengthen long-term regulation of the nervous system.
Although additional research is needed, both approaches appear to work through similar underlying mechanisms by improving autonomic regulation, increasing attention to internal bodily signals, and strengthening emotional self-regulation.
Addiction is not simply driven by exposure to drugs or alcohol. It is also shaped by how the brain responds to stress. Many people in recovery describe cravings as feeling automatic, almost as though the body reacts before conscious thought has a chance to intervene.
Controlled breathing may help interrupt this process.
Slowing the breath activates neural pathways that promote calmness while reducing excessive activation of the body's stress response. As physiological arousal decreases, people may find it easier to pause, think clearly, and choose healthier coping strategies instead of reacting impulsively.
Breathing exercises are unlikely to eliminate cravings entirely. Rather, they may reduce their intensity and make them easier to manage, particularly when combined with established treatments such as counseling, medication, and peer support.
The evidence was less convincing for withdrawal symptoms and addiction severity.
Only a small number of studies examined these outcomes, and their results varied considerably. Some reported improvements, while others found little or no benefit.
Because so few studies were available, researchers could not determine with confidence whether breathing interventions reduce withdrawal symptoms.
This does not necessarily mean breathing is ineffective. Instead, it highlights an important distinction between absence of evidence and evidence of absence. At present, there simply is not enough high-quality research to draw firm conclusions.
One of the most encouraging developments is that breathing interventions no longer require specialized clinics or expensive equipment.
Earlier studies relied on multiple in-person sessions with trained clinicians. More recent research has successfully delivered breathing programs through smartphone applications and wearable sensors that provide real-time physiological feedback.
Given that mobile phones are now owned by most adults worldwide, these technologies could make evidence-based breathing interventions available to millions of people who otherwise have limited access to addiction treatment.
Although the findings are encouraging, several limitations deserve consideration.
Many of the studies enrolled relatively small numbers of participants, and only a few evaluated outcomes beyond craving. Long-term follow-up was often limited, making it difficult to determine whether benefits persist months or years after treatment.
Most studies also relied on participants reporting their own cravings rather than measuring long-term changes in substance use itself. Finally, differences in breathing techniques, treatment duration, and study design make direct comparisons challenging.
Future research should include larger randomized clinical trials, standardized outcome measures, and longer follow-up periods to determine how breathing interventions fit within comprehensive addiction care.
This systematic review brings together evidence from 20 studies involving 1,249 participants and provides encouraging support for breathing-based interventions as an addition to addiction treatment.
The strongest evidence indicates that controlled breathing can reduce cravings, one of the most important drivers of relapse. While the evidence for withdrawal symptoms and long-term recovery remains limited, breathing exercises offer several practical advantages. They are inexpensive, safe, easy to learn, and increasingly accessible through smartphones and wearable technology.
No one should view breathing exercises as a replacement for proven treatments such as medication, behavioral therapy, or social support. Addiction is a complex medical condition that often requires a comprehensive treatment plan.
Instead, breathing may serve as another evidence-based tool. Like physical therapy after orthopedic surgery, it is unlikely to solve the problem by itself, but it can strengthen recovery when combined with other effective treatments.
As larger and higher-quality studies emerge, controlled breathing may become one of the simplest and most scalable ways to help people manage cravings, improve emotional regulation, and support long-term recovery.
The lessons of this research extend well beyond addiction. Chronic stress and persistent anxiety keep the body’s “accelerator” pressed for millions of people, and the same principle applies: anything that helps the nervous system shift back toward its parasympathetic “brake” can make daily challenges easier to manage. Controlled breathing is one such tool. Nutrition offers another, and one of the best-studied options is L-theanine, an amino acid found almost exclusively in tea leaves and largely responsible for the calm-but-alert feeling many people associate with a cup of green tea.
L-theanine crosses the blood–brain barrier and influences several signaling systems involved in mood and arousal, including GABA, serotonin, dopamine, and glutamate. It also increases alpha-wave activity in the brain, a pattern linked to relaxed yet attentive wakefulness(11).
In a placebo-controlled study, L-theanine blunted increases in heart rate and salivary immunoglobulin A, a physiological marker of stress, during a demanding mental task(12). A 4-week randomized trial in healthy adults found that 200 mg per day reduced stress-related symptoms, lowered anxiety scores, and improved sleep quality compared with placebo(13), and a systematic review of controlled trials concluded that 200 to 400 mg per day may help reduce stress and anxiety in people exposed to stressful conditions(14). Like breathing, L-theanine does not eliminate stress. Instead, it appears to soften the body’s reaction to it.
VOSTOKX was formulated to help with the transition from a demanding day into deliberate downtime, and L-theanine is a core part of its VOSTOKX Complex™, alongside magnesium L-threonate and vitamin B6, which support normal nerve signaling and neurotransmitter synthesis. For someone carrying a heavy load of stress, pairing a few minutes of slow, controlled breathing with an evening routine that includes VOSTOK offers a simple, two-pronged approach: breathing to interrupt stress in the moment, and L-theanine to help the mind settle as the day winds down.
Magnesium acts as a natural gatekeeper on NMDA receptors, the brain’s main excitatory glutamate receptors, helping keep nerve signaling balanced rather than overstimulated. Many common forms of magnesium, however, do little to raise magnesium levels in the brain itself. Magnesium L-threonate was developed to address that gap. In animal studies, it raised brain magnesium, increased synaptic density in the hippocampus, and improved learning and memory(15). In a related study, elevating brain magnesium with magnesium L-threonate strengthened the extinction of learned fear, the process by which the brain learns that a once-threatening cue is now safe, through effects in the prefrontal cortex(16).
That finding is notable because fear extinction is the same process many cognitive therapies for anxiety rely on.
In people, a systematic review of 18 studies of magnesium supplementation found evidence suggestive of benefit for subjective anxiety in individuals prone to anxiety, although the overall quality of that evidence was limited(17).
More recently, a randomized, double-blind, placebo-controlled trial in 80 adults aged 35 to 55 with self-reported sleep problems found that 1 g per day of magnesium L-threonate for 21 days improved deep and REM sleep scores measured by a wearable ring, along with mood, energy, mental alertness, and daytime productivity, compared with placebo(18).
Within VOSTOKX, magnesium L-threonate complements L-theanine. L-theanine helps quiet the mind as the evening begins, while magnesium L-threonate supports the brain magnesium levels that underlie balanced nerve signaling and restorative sleep.
That's important for stress control, because sleep and stress are tightly linked.
A poor night’s sleep tends to amplify the next day’s stress response, while good sleep makes emotions easier to regulate. Taken together, slow, controlled breathing and an evening routine built around VOSTOKX’s L-theanine and magnesium L-threonate offer a practical way to calm the body’s stress response in the moment, wind down at night, and wake better prepared for the demands of the next day.
References:
Your next step
Keep reading
